Therapeutic category of drugs in Japan [BR:br08301]
3 Agents affecting metabolism
39 Other agents affecting metabolism
399 Miscellaneous
3999 Others
D01146 Iguratimod (JAN/INN)
Drug groups [BR:br08330]
Anti-inflammatory
DG01985 Disease modifying anti-rheumatic drug (DMARD)
D01146 Iguratimod
Metabolizing enzyme substrate
DG02928 NAT substrate
D01146 Iguratimod
Drug classes [BR:br08332]
Antirheumatic agent
DG01985 Disease modifying anti-rheumatic drug (DMARD)
D01146 Iguratimod
Target-based classification of drugs [BR:br08310]
Not elsewhere classified
Signaling molecules
Transcription factor
NFKB1
D01146 Iguratimod (JAN/INN) <JP>
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D01146
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D01146
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D01146
Other DBs
CAS:
123663-49-0
PubChem:
7848209
ChEBI:
31689
LigandBox:
D01146
KCF data
ATOM 26
1 C8x C 25.2173 -17.9350
2 C8x C 25.2173 -20.7366
3 C8y C 24.0084 -20.0362
4 C8y C 24.0143 -18.6354
5 C8y C 22.8042 -17.9299
6 O2x O 22.7922 -20.7315
7 C8x C 21.5821 -20.0259
8 C8y C 21.5948 -18.6288
9 N1b N 20.3911 -17.9192
10 C4a C 19.1749 -18.6069
11 C8y C 26.4334 -18.6354
12 C8y C 26.4334 -20.0362
13 N1b N 27.6464 -20.7366
14 O2a O 27.6464 -17.9350
15 S4a S 28.8592 -20.0362
16 C1a C 30.0721 -20.7370
17 C8y C 27.6464 -16.5342
18 C8x C 28.8616 -15.8374
19 C8x C 28.8616 -14.4366
20 C8x C 27.6484 -13.7362
21 C8x C 26.4354 -14.4366
22 C8x C 26.4354 -15.8374
23 O5x O 22.8069 -16.5291
24 O4a O 17.9682 -17.8955
25 O3c O 30.0627 -19.3289
26 O3c O 27.6360 -19.3358
BOND 28
1 5 8 1
2 11 12 2
3 12 13 1
4 13 15 1
5 14 11 1
6 7 6 1
7 6 3 1
8 15 16 1
9 2 12 1
10 14 17 1
11 11 1 1
12 1 4 2
13 7 8 2
14 8 9 1
15 17 18 2
16 18 19 1
17 19 20 2
18 20 21 1
19 21 22 2
20 22 17 1
21 9 10 1
22 5 23 2
23 3 2 2
24 10 24 2
25 3 4 1
26 15 25 2
27 4 5 1
28 15 26 2